Ali Azhdarinia

13PUBLICATIONS
32CO-AUTHORS
Medical infection agents (incl. prions)Molecular targetsGene and molecular therapyPredictive and prognostic markersBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Nov 27, 2025
RBM39 Contributes to MGMT Maintenance in Response to Temozolomide-Induced DNA Damage.

Vahid Khalaj, Jack T Adams, Solmaz AghaAmiri

|Sep 26, 2025
Somatostatin Receptor 2 Overexpression in Hepatocellular Carcinoma: Implications for Cancer Biology and Therapeutic Applications.

Servando Hernandez Vargas, Solmaz Aghaamiri, Jack T Adams

|Jan 25, 2025
SSTR2-Targeted Theranostics in Hepatocellular Carcinoma.

Majid Momeny, Solmaz AghaAmiri, Servando Hernandez Vargas

|Dec 18, 2024
Antibody-Drug Conjugates Targeting the EGFR Ligand Epiregulin Elicit Robust Antitumor Activity in Colorectal Cancer.

Joan Jacob, Yasuaki Anami, Peyton C High

|Nov 28, 2024
Antibody-Drug Conjugates Targeting the EGFR Ligand Epiregulin Elicit Robust Anti-Tumor Activity in Colorectal Cancer.

Joan Jacob, Yasuaki Anami, Peyton High

|Feb 12, 2024
Somatostatin Receptor Subtype-2 Targeting System for Specific Delivery of Temozolomide.

Solmaz AghaAmiri, Sukhen C Ghosh, Servando Hernandez Vargas

Pageof 3

Frequent Collaborators

8 joint publications

Solmaz AghaAmiri

8 joint publications

Servando Hernandez Vargas

3 joint publications

Kendra S Carmon

3 joint publications

Tyler M Bateman